Adipose tissue and skeletal muscle plasticity modulates metabolic health

Archives of Physiology and Biochemistry

Volumn 114, Issue 5, 2008, Pages 357-368

  Ukropec, Jozef ^a   Ukropcova, Barbara ^a   Kurdiova, Timea ^a   Gasperikova, Daniela ^a   Klimes, Iwar ^a  

^a INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

Author keywords

Adipokines; Adipose tissue; Hypoxia; Inflammation; Insulin resistance; Myokines; Obesity; Skeletal muscle; Tissue plasticity

Indexed keywords

ADIPOSE TISSUE; ANIMAL; ANOXIA; CYTOLOGY; EXERCISE; HEALTH; HUMAN; INFLAMMATION; METABOLISM; OBESITY; PATHOLOGY; PHYSIOLOGY; REVIEW; SKELETAL MUSCLE;

ADIPOSE TISSUE; ANIMALS; ANOXIA; EXERCISE; HEALTH; HUMANS; INFLAMMATION; MUSCLE, SKELETAL; OBESITY;

EID: 57649136525     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.1080/13813450802535812     Document Type: Review

References (134)

1. Aguiari P, Leo S, Zavan B, Vindigni V, Rimessi A, Bianchi K, Franzin C, Cortivo R, Rossato M, Vettor R, et al. 2008. High glucose induces adipogenic differentiation of muscle-derived stem cells. Proc Natl Acad Sci USA 105(4):1226-31.
2. Ahima RS, Lazar MA. 2008. Adipokines and the peripheral and neural control of energy balance. Mol Endocrinol 00:00-00.
3. Alpert MA, Fraley MA, Birchem JA, Senkottaiyan N. 2005. Management of obesity cardiomyopathy. Expert Rev Cardiovasc Ther 3(2):225-30.
4. Baldwin KM, Haddad F. 2002. Skeletal muscle plasticity: cellular and molecular responses to altered physical activity paradigms. Am J Phys Med Rehabil 81(11 Suppl):S40-51.
5. Bao Y, Bing C, Hunter L, Jenkins JR, Wabitsch M, Trayhurn P. 2005. Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed and secreted by human SGBS adipocytes. FEBS Lett 579(1):41-7.
6. Bar-Shalom R, Gaitini D, Keidar Z, Israel O. 2004. Non-malignant FDG uptake in infradiaphragmatic adipose tissue: a new site of physiological tracer biodistribution characterised by PET/CT. Eur J Nucl Med Mol Imaging 31(8):1105-13.
7. Barrilleaux B, Phinney DG, Prockop DJ, O'Connor KC. 2006. Review: ex vivo engineering of living tissues with adult stem cells. Tissue Eng 12(11):3007-19.
8. Bartness TJ, Kay Song C, Shi H, Bowers RR, Foster MT. 2005. Brain-adipose tissue cross talk. Proc Nutr Soc 64(1):53-64.
9. Bays H. 2005. Adiposopathy, metabolic syndrome, quantum physics, general relativity, chaos and the theory of everything. Expert Rev Cardiovasc Ther 3(3):393-404.
10. Bays H, Blonde L, Rosenson R. 2006. Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients? Expert Rev Cardiovasc Ther 4(6):871-95.
11. Bays HE, Gonzalez-Campoy JM, Bray GA, Kitabchi AE, Bergman DA, Schorr AB, Rodbard HW, Henry RR. 2008. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev Cardiovasc Ther 6(3):343-68.
12. Bogacka I, Xie H, Bray GA, Smith SR. 2005. Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo. Diabetes 54(5):1392-9.
13. Bolster DR, Kimball SR, Jefferson LS. 2003. Translational control mechanisms modulate skeletal muscle gene expression during hypertrophy. Exerc Sport Sci Rev 31(3):111-6.
14. Bostrom P, Magnusson B, Svensson PA, Wiklund O, Boren J, Carlsson LM, Stahlman M, Olofsson SO, Hulten LM. 2006. Hypoxia converts human macrophages into triglyceride-loaded foam cells. Arterioscler Thromb Vasc Biol 26(8):1871-6.
15. Broholm C, Mortensen OH, Nielsen S, Akerstrom T, Zankari A, Dahl B, Pedersen BK. 2008. Exercise induces expression of Leukemia Inhibitory Factor LIF in human skeletal muscle. J Physiol 00:00-00.
16. Cannon B, Nedergaard J. 2004. Brown adipose tissue: function and physiological significance. Physiol Rev 84(1):277-359.
17. Carriere A, Carmona MC, Fernandez Y, Rigoulet M, Wenger RH, Penicaud L, Casteilla L. 2004. Mitochondrial reactive oxygen species control the transcription factor CHOP-10/GADD153 and adipocyte differentiation: a mechanism for hypoxia-dependent effect. J Biol Chem 279(39):40462-9.
18. Casteilla L, Dani C. 2006. Adipose tissue-derived cells: from physiology to regenerative medicine. Diabetes Metab 32(5 Pt 1):393-401.
19. Chandel NS, Budinger GR. 2007. The cellular basis for diverse responses to oxygen. Free Radic Biol Med 42(2):165-74.
20. Chavey C, Mari B, Monthouel MN, Bonnafous S, Anglard P, Van Obberghen E, Tartare-Deckert S. 2003. Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation. J Biol Chem 278(14): 11888-96.
21. Collins S, Cao W, Robidoux J. 2004. Learning new tricks from old dogs: beta-adrenergic receptors teach new lessons on firing up adipose tissue metabolism. Mol Endocrinol 18(9):2123-31.
22. Cramer T, Johnson RS. 2003. A novel role for the hypoxia inducible transcription factor HIF-1alpha: critical regulation of inflammatory cell function. Cell Cycle 2(3):192-3.
23. Cramer T, Yamanishi Y, Clausen BE, Forster I, Pawlinski R, Mackman N, Haase VH, Jaenisch R, Corr M, Nizet V, et al. 2003. HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 112(5):645-57.
24. Daval M, Foufelle F, Ferré P. 2006. Functions of AMP-activated protein kinase in adipose tissue. J Physiol 574(Pt 1):55-62.
25. DeFronzo, RA. 2004. Dysfunctional fat cells, lipotoxicity and type 2 diabetes. Int J Clin Pract 143 (Suppl):9-21.
26. Delarue J, Magnan C. 2007. Free fatty acids and insulin resistance. Curr Opin Clin Nutr Metab Care 10(2):142-8.
27. Erbay E, Cao H, Hotamisligil GS. 2007. Adipocyte/macrophage fatty acid binding proteins in metabolic syndrome. Curr Atheroscler Rep 9(3):222-9.
28. Fantuzzi G. 2005. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115(5):911-9; quiz 920.
29. Farmer SR. 2006. Transcriptional control of adipocyte formation. Cell Metab 4(4):263-73.
30. Fluck M. 2006. Functional, structural and molecular plasticity of mammalian skeletal muscle in response to exercise stimuli. J Exp Biol 209(Pt 12):2239-48.
31. Fluck M, Hoppeler H. 2003. Molecular basis of skeletal muscle plasticity - from gene to form and function. Rev Physiol Biochem Pharmacol 146:159-216.
32. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, Vasan RS, Murabito JM, Meigs JB, Cupples LA, et al. 2007. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 116(1):39-48.
33. Freyssenet D, Irrcher I, Connor MK, Di Carlo M, Hood DA. 2004. Calcium-regulated changes in mitochondrial phenotype in skeletal muscle cells. Am J Physiol Cell Physiol 286(5):C1053-61.
34. Freyssenet D. 2007. Energy sensing and regulation of gene expression in skeletal muscle. J Appl Physiol 102(2):529-40.
35. Garcia CA, Van Nostrand D, Van Nostrand D, Atkins F, Acio E, Butler C, Esposito G, Kulkarni K, Majd M. 2006. Reduction of brown fat 2-deoxy-2-[F-18]fluoro-D-glucose uptake by controlling environmental temperature prior to positron emission tomography scan. Mol Imaging Biol 8(1):24-9.
36. Garcia CA, Van Nostrand D, Majd M, Atkins F, Acio E, Sheikh A, Butler C. 2004. Benzodiazepine-resistant brown fat pattern in positron emission tomography: two case reports of resolution with temperature control. Mol Imaging Biol 6(6):368-72.
37. Gauthier MS, Miyoshi H, Souza SC, Cacicedo JM, Saha AK, Greenberg AS, Ruderman NB. 2008. AMP-activated protein kinase is activated as a consequence of lipolysis in the adipocyte: potential mechanism and physiological relevance. J Biol Chem. 283(24):16514-24.
38. Ghizzoni L, Mastorakos G, Ziveri M, Furlini M, Solazzi A, Vottero A, Bernasconi S. 2001. Interactions of leptin and thyrotropin 24-hour secretory profiles in short normal children. J Clin Endocrinol Metab 86(5):2065-72.
39. Goossens GH. 2007. The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Physiol Behav 00:00-00.
40. Gordon S. 2007. Macrophage heterogeneity and tissue lipids. J Clin Invest 117(1):89-93.
41. Gordon S, Taylor PR. 2005. Monocyte and macrophage heterogeneity. Nat Rev Immunol 5(12):953-64.
42. Granneman JG, Burnazi M, Zhu Z, Schwamb LA. 2003. White adipose tissue contributes to UCP1-independent thermogenesis. Am J Physiol Endocrinol Metab 285(6):E1230-6.
43. Grumbles RM, Casella GT, Rudinsky MJ, Wood PM, Sesodia S, Bent M, Thomas CK. 2007. Long-term delivery of FGF-6 changes the fiber type and fatigability of muscle reinnervated from embryonic neurons transplanted into adult rat peripheral nerve. J Neurosci Res 85(9):1933-42.
44. Guilak F, Lott KE, Awad HA, Cao Q, Hicok KC, Fermor B, Gimble JM. 2006. Clonal analysis of the differentiation potential of human adipose-derived adult stem cells. J Cell Physiol 206(1):229-37.
45. Hamdy O, Porramatikul S, Al-Ozairi E. 2006. Metabolic obesity:the paradox between visceral and subcutaneous fat. Curr Diabetes Rev 2(4):367-73.
46. Himms-Hagen J. 2004. Exercise in a pill: feasibility of energy expenditure targets. Curr Drug Targets CNS Neurol Disord 3(5):389-409.
47. Hirai K, Hussey HJ, Barber MD, Price SA, Tisdale MJ. 1998. Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients. Cancer Res. 58(11):2359-65.
48. Hocking SL, Chisholm DJ, James DE. 2008. Studies of regional adipose transplantation reveal a unique and beneficial interaction between subcutaneous adipose tissue and the intra-abdominal compartment. Diabetologia 51(5):900-2.
49. Hosogai N, Fukuhara A, Oshima K, Miyata Y, Tanaka S, Segawa K, Furukawa S, Tochino Y, Komuro R, Matsuda M, Shimomura I. 2007. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 56(4):901-11.
50. Hu G, Tuomilehto J, Silventoinen K, Barengo NC, Peltonen M, Jousilahti P. 2005. The effects of physical activity and body mass index on cardiovascular, cancer and all-cause mortality among 47 212 middle-aged Finnish men and women. Int J Obes Lond 29(8):894-902.
51. Huang LE, Gu J, Schau M, Bunn HF. 1998. Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 95(14):7987-92.
52. Huber J, Loffler M, Bilban M, Reimers M, Kadl A, Todoric J, Zeyda M, Geyeregger R, Schreiner M, Weichhart T, Leitinger N, Waldhausl W, Stulnig TM. 2007. Prevention of high-fat diet-induced adipose tissue remodelling in obese diabetic mice by n-3 polyunsaturated fatty acids. Int J Obes Lond 31(6):1004-13.
53. Inouye KE, Shi H, Howard JK, Daly CH, Lord GM, Rollins BJ, Flier JS. 2007. Absence of CC chemokine ligand 2 does not limit obesity-associated infiltration of macrophages into adipose tissue. Diabetes 56(9):2242-50.
54. Jensen MD. 2006. Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model. Obesity Silver Spring 14(Suppl 1):20S-24S.
55. Jezek P, Zackova M, Ruzicka M, Skobisova E, Jaburek M. 2004. Mitochondrial uncoupling proteins - facts and fantasies. Physiol Res 53(Suppl 1):S199-211.
56. Joffe BI, Panz VR, Raal FJ. 2001. From lipodystrophy syndromes to diabetes mellitus. Lancet 357(9266):1379-81.
57. Joseph AM, Pilegaard H, Litvintsev A, Leick L, Hood DA. 2006. Control of gene expression and mitochondrial biogenesis in the muscular adaptation to endurance exercise. Essays Biochem 42:13-29.
58. Kabir M, Catalano KJ, Ananthnarayan S, Kim SP, Van Citters GW, Dea MK, Bergman RN. 2005. Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance. Am J Physiol Endocrinol Metab 288(2):E454-61.
59. Kamei N, Tobe K, Suzuki R, Ohsugi M, Watanabe T, Kubota N, Ohtsuka-Kowatari N, Kumagai K, Sakamoto K, Kobayashi M, Yamauchi T. 2006. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem 281(36):26602-14.
60. Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, Kitazawa R, Kitazawa S, Miyachi H, Maeda S, Egashira K, Kasuga M. 2006. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 116(6):1494-505.
61. Kelly LJ, Vicario PP, Thompson GM, Candelore MR, Doebber TW, Ventre J, Wu MS, Meurer R, Forrest MJ, Conner MW, Cascieri MA, Moller DE. 1998. Peroxisome proliferators-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein UCP-1, UCP-2, UCP-3 gene expression. Endocrinology 139(12):4920-7.
62. Kim KH, Song MJ, Chung J, Park H, Kim JB. 2005. Hypoxia inhibits adipocyte differentiation in a HDAC-independent manner. Biochem Biophys Res Commun 333(4):1178-84.
63. Kintscher U, Hartge M, Hess K, Foryst-Ludwig A, Clemenz M, Wabitsch M, Fischer-Posovszky P, Barth TF, Dragun D, Skurk T, et al. 2008. T-lymphocyte infiltration in visceral adipose tissue. A primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol. 28(7):1304-10.
64. Kralisch S, Klein J, Lossner U, Bluher M, Paschke R, Stumvoll M, Fasshauer M. 2005. Proinflammatory adipocytokines induce TIMP-1 expression in 3T3-L1 adipocytes. FEBS Lett 579(28):6417-22.
65. Kralisch S, Lossner U, Bluher M, Paschke R, Stumvoll M, Fasshauer M. 2006. Tissue inhibitor of metalloproteinase 1 expression and secretion are induced by beta-adrenergic stimulation in 3T3-L1 adipocytes. J Endocrinol 189(3):665-70.
66. Lehrke M, Lazar MA. 2005. The many faces of PPARgamma. Cell 123(6):993-9.
67. Li P, Zhu Z, Lu Y, Granneman JG. 2005. Metabolic and cellular plasticity in white adipose tissue II: role of peroxisome proliferators-activated receptor-alpha. Am J Physiol Endocrinol Metab 289(4):E617-26.
68. Lijnen HR, Demeulemeester D, Van Hoef B, Collen D, Maquoi E. 2003. Deficiency of tissue inhibitor of matrix metalloproteinase-1 TIMP-1 impairs nutritionally induced obesity in mice. Thromb Haemost 89(2):249-55.
69. Lilla J, Stickens D, Werb Z. 2002. Metalloproteases and adipogenesis: a weighty subject. Am J Pathol 160(5):1551-4.
70. Linton MF, Fazio S. 2003. Macrophages, inflammation, and atherosclerosis. Int J Obes Relat Metab Disord 27(Suppl 3):S35-40.
71. Liu L, Simon MC. 2004. Regulation of transcription and translation by hypoxia. Cancer Biol Ther 3(6):492-7.
72. Lumeng CN, Bodzin JL, Saltiel AR. 2007. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117(1):175-84.
73. Maquoi E, Munaut C, Colige A, Collen D, Lijnen HR. 2002. Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity. Diabetes 51(4):1093-101.
74. Marrades MP, Martínez JA, Moreno-Aliaga MJ. 2008. ZAG, a lipid mobilizing adipokine, is downregulated in human obesity. J Physiol Biochem 64(1):61-6.
75. Muoio DM, Koves TR. 2007. Skeletal muscle adaptation to fatty acid depends on coordinated actions of the PPARs and PGC1 alpha: implications for metabolic disease. Appl Physiol Nutr Metab 32(5):874-83.
76. Nedergaard J, Bengtsson T, Cannon B. 2007. Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab 293(2):E444-52.
77. Neels JG, Olefsky JM. 2006. Inflamed fat: what starts the fire? J Clin Invest 116(1):33-5.
78. Nielsen AR, Pedersen BK. 2007. The biological roles of exercise-induced cytokines:IL-6, IL-8, and IL-15. Appl Physiol Nutr Metab 32(5):833-9.
79. Nomiyama T, Perez-Tilve D, Ogawa D, Gizard F, Zhao Y, Heywood EB, Jones KL, Kawamori R, Cassis LA, Tschop MH, Bruemmer D. 2007. Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. J Clin Invest 117(10):2877-88.
80. Nunn AV, Bell J, Barter P. 2007. The integration of lipid-sensing and anti-inflammatory effects: how the PPARs play a role in metabolic balance. Nucl Recept 5(1):1.
81. Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, Morel CR, Subramanian V, Mukundan L, Eagle AR, Vats D, Brombacher F, Ferrante AW, Chawla A. 2007. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 447(7148):1116-20.
82. Parysow O, Mollerach AM, Jager V, Racioppi S, San Roman J, Gerbaudo VH. 2007. Low-dose oral propranolol could reduce brown adipose tissue F-18 FDG uptake in patients undergoing PET scans. Clin Nucl Med 32(5):351-7.
83. Pedersen BK. 2007. IL-6 signalling in exercise and disease. Biochem Soc Trans 35(Pt 5):1295-7.
84. Pedersen BK, Akerstrom TC, Nielsen AR, Fischer CP. 2007. Role of myokines in exercise and metabolism. J Appl Physiol 103(3):1093-8.
85. Pedersen BK, Febbraio M. 2005. Muscle-derived interleukin-6 - a possible link between skeletal muscle, adipose tissue, liver, and brain. Brain Behav Immun 19(5):371-6.
86. Pedersen BK, Steensberg A, Schjerling P. 2001. Exercise and interleukin-6. Curr Opin Hematol 8(3):137-41.
87. Plomgaard P, Keller P, Keller C, Pedersen BK. 2005. TNF-alpha, but not IL-6, stimulates plasminogen activator inhibitor-1 expression in human subcutaneous adipose tissue. J Appl Physiol 98(6):2019-23.
88. Ramacciotti C, Schneegans O, Lang H, Lindner V, Claria M, Moreau F, Chenard MP, Pinget M, Kessler L. 2006. Diffuse uptake of brown fat on computed-tomography coupled positron emission tomoscintigraphy PET-CT for the exploration of extraadrenal pheochromocytoma. Ann Endocrinol Paris 67(1):14-9.
89. Ravussin E, Smith SR. 2002. Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus. Ann N Y Acad Sci 967:363-78.
90. Rong JX, Qiu Y, Hansen MK, Zhu L, Zhang V, Xie M, Okamoto Y, Mattie MD, Higashiyama H, Asano S, Strum JC, Ryan TE. 2007. Adipose mitochondrial biogenesis is suppressed in db/db and high-fat diet-fed mice and improved by rosiglitazone. Diabetes 56(7):1751-60.
91. Rosen ED, Hsu CH, Wang X, Sakai S, Freeman MW, Gonzalez FJ, Spiegelman BM. 2002. C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes Dev 16(1):22-6.
92. Rossi GP, Sticchi D, Giuliani L, Bernante P, Zavattiero S, Pessina AC, Nussdorfer GG. 2006. Adiponectin receptor expression in the human adrenal cortex and aldosterone-producing adenomas. Int J Mol Med 17(6):975-80.
93. Ruderman NB, Keller C, Richard AM, Saha AK, Luo Z, Xiang X, Giralt M, Ritov VB, Menshikova EV, Kelley DE, Hidalgo J, Pedersen BK, Kelly M. 2006. Interleukin-6 regulation of AMP-activated protein kinase. Potential role in the systemic response to exercise and prevention of the metabolic syndrome. Diabetes. 55(Suppl 2):S48-54.
94. Rundhaug JE. 2005. Matrix metalloproteinases and angiogenesis. J Cell Mol Med 9(2):267-85.
95. Russell ST. and Tisdale MJ. 2005. Effect of eicosapentaenoic acid EPA on expression of a lipid mobilizing factor in adipose tissue in cancer cachexia. Prostaglandins Leukot Essent Fatty Acids 72(6):409-14.
96. Samec S, Seydoux J, Dulloo AG. 1998. Interorgan signalling between adipose tissue metabolism and skeletal muscle uncoupling protein homologs: is there a role for circulating free fatty acids? Diabetes 47(11):1693-8.
97. Schaffler A, Scholmerich J, Buchler C. 2005a. Mechanisms of disease:adipocytokines and visceral adipose tissue - emerging role in intestinal and mesenteric diseases. Nat Clin Pract Gastroenterol Hepatol 2(2):103-11.
98. Schaffler A, Scholmerich J, Buchler C. 2005b. Mechanisms of disease: adipocytokines and visceral adipose tissue - emerging role in nonalcoholic fatty liver disease. Nat Clin Pract Gastroenterol Hepatol 2(6):273-80.
99. Schmidt A, Bierwirth S, Weber S, Platen P, Schinkothe T, Bloch W. 2007. Short intensive exercise increase the migratory activity of mesenchymal stem cells. Br J Sports Med [doi:10.1136/bjsm.2007.043208]
100. Seale P, Bjork, B, Yang W, Kajimura S, Chin S, Kuang S, Scime A, Devarakonda S, Conroe HM, Erdjument-Bromage H, et al. 2008. PRDM16 controls a brown fat/skeletal muscle switch. Nature 454(7207):961-7.
101. Sell H, Dietze-Schroeder D, Eckel J. 2006. The adipocyte-myocyte axis in insulin resistance. Trends Endocrinol Metab 17(10):416-22.
102. Sell H, Eckardt K, Taube A, Tews D, Gurgui M, Van Echten-Deckert G, Eckel J. 2008. Skeletal muscle insulin resistance induced by adipocyte-conditioned medium: underlying mechanisms and reversibility. Am J Physiol Endocrinol Metab. 294(6):E1070-7.
103. Semenza GL. 2000. HIF-1 and human disease: one highly involved factor. Genes Dev 14(16):1983-91.
104. Sethi JK, Vidal-Puig AJ. 2007. Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res 48(6):1253-62.
105. Shibasaki M, Takahashi K, Itou T, Miyazawa S, Ito M, Kobayashi J, Bujo H, Saito Y. 2002. Alterations of insulin sensitivity by the implantation of 3T3-L1 cells in nude mice. A role for TNF-alpha? Diabetologia 454:518-26.
106. Skopkova M, Penesova A, Sell H, Radikova Z, Vlcek M, Imrich R, Koska J, Ukropec J, Eckel J, Klimes I, Gasperikova D. 2007. Protein array reveals differentially expressed proteins in subcutaneous adipose tissue in obesity. Obesity Silver Spring 15(10):2396-406.
107. Sponarova J, Mustard KJ, Horakova O, Flachs P, Rossmeisl M, Brauner P, Bardova K, Thomason-Hughes M, Braunerova R, Janovska P, Hardie DG, Kopecky J. 2005. Involvement of AMP-activated protein kinase in fat depot-specific metabolic changes during starvation. FEBS Lett. 579(27):6105-10.
108. Tchernof A. 2007. Visceral adipocytes and the metabolic syndrome. Nutr Rev 65(6 Pt 2):S24-9.
109. Tran TT, Yamamoto Y, Gesta S, Kahn CR. 2008. Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab 7(5):410-20.
110. Trayhurn P. 2005. The biology of obesity. Proc Nutr Soc 64(1):31-8.
111. Trayhurn P, Bing C, Wood IS. 2006. Adipose tissue and adipokines - energy regulation from the human perspective. J Nutr 136(7 Suppl):1935S-1939S.
112. Trayhurn P, Wood IS. 2005. Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans 33(Pt 5):1078-81.
113. Tseng YH, Kokkotou E, Schulz TJ, Huang TL, Winnay JN, Taniguchi CM, Tran TT, Suzuki R, Espinoza DO, Yamamoto Y, et al. 2008. New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature. 454(7207):1000-4.
114. Ukropec J, Anunciado RP, Ravussin Y, Hulver MW, Kozak LP. 2006. UCP1-independent thermogenesis in white adipose tissue of cold-acclimated Ucp1-/mice. J Biol Chem 281(42):31894-908.
115. Ukropec J, Penesová A, Škopková M, Pura M, Vlček M, Rádiková Z, Imrich R, Ukropcová B, Tajtáková M, Koška J, et al. 2008. Adipokine protein expression pattern in growth hormone deficiency predisposes to the increased fat cell size and to the whole body metabolic derangements. J Clin Endocrinol and Metab 93(6):2255-62.
116. Unger RH. 2002. Lipotoxic diseases. Annu Rev Med 53:319-36.
117. Uno K, Katagiri H, Yamada T, Ishigaki Y, Ogihara T, Imai J, Hasegawa Y, Gao J, Kaneko K, Iwasaki H, et al. 2006. Neuronal pathway from the liver modulates energy expenditure and systemic insulin sensitivity. Science 312(5780):1656-9.
118. Valassi E, Scacchi M, Cavagnini F. 2008. Neuroendocrine control of food intake. Nutr Metab Cardiovasc Dis 18(2):158-68.
119. Wagenknecht LE, Langefeld CD, Scherzinger AL, Norris JM, Haffner SM, Saad MF, Bergman RN. 2003. Insulin sensitivity, insulin secretion, and abdominal fat:the Insulin Resistance Atherosclerosis Study IRAS Family Study. Diabetes 52(10):2490-6.
120. Wajchenberg BL. 2000. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21(6):697-738.
121. Waki H, Park KW, Mitro N, Pei L, Damoiseaux R, Wilpitz DC, Reue K, Saez E, Tontonoz P. 2007. The small molecule harmine is an antidiabetic cell-type-specific regulator of PPARgamma expression. Cell Metab 5(5):357-70.
122. Wang B, Wood IS, Trayhurn P. 2007. Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytes. Pflugers Arch 455(3):479-92.
123. Wang B, Wood IS, Trayhurn P. 2008. PCR arrays identify metallothionein-3 as a highly hypoxia-inducible gene in human adipocytes. Biochem Biophys Res Commun 368(1):88-93.
124. Wang H, Zhang Y, Yehuda-Shnaidman E, Medvedev AV, Kumar N, Daniel KW, Robidoux J, Czech MP, Mangelsdorf DJ, Collins S. 2008. Liver X receptor alpha is a transcriptional repressor of the uncoupling protein 1 gene and the brown fat phenotype. Mol Cell Biol 28(7):2187-200.
125. Weisberg SP, Hunter D, Huber R, Lemieux J, Slaymaker S, Vaddi K, Charo I, Leibel RL, Ferrante AW, Jr. 2006. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 1161:115-24.
126. Weiss, R. 2007. Fat distribution and storage:how much, where, and how? Eur J Endocrinol 157(Suppl 1):S39-45.
127. Wellen KE, Hotamisligil GS. 2005. Inflammation, stress, and diabetes. J Clin Invest 115(5):1111-9.
128. Weyer C, Foley JE, Bogardus C, Tataranni PA, Pratley RE. 2000. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 43(12):1498-506.
129. Wilson-Fritch L, Burkart A, Bell G, Mendelson K, Leszyk J, Nicolon S, Czech M, Corvera S. 2003. Mitochondrial biogenesis and remodelling during adipogenesis and in response to the insulin sensitizer rosiglitazone. Mol Cell Biol 23(3):1085-94.
130. Winder WW, Thomson DM. 2007. Cellular energy sensing and signalling by AMP-activated protein kinase. Cell Biochem Biophys 47(3):332-47.
131. Wright DC, Geiger PC, Han DH, Jones TE, Holloszy JO. 2007. Calcium induces increases in peroxisome proliferators-activated receptor gamma coactivator-1alpha and mitochondrial biogenesis by a pathway leading to p38 mitogen-activated protein kinase activation. J Biol Chem 282(26):18793-9.
132. Yamauchi M, Kambe F, Cao X, Lu X, Kozaki Y, Oiso Y, Seo H. 2008. Thyroid hormone activates AMP-activated protein kinase via intracellular calcium mobilization and activation of calcium/calmodulin-dependent protein kinase kinase-{beta}. Mol Endocrinol 00:00-00.
133. Ye J, Gao Z, Yin J, He Q. 2007. Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab 293(4):E1118-28.
134. Yun Z, Maecker HL, Johnson RS, Giaccia AJ. 2002. Inhibition of PPAR gamma 2 gene expression by the HIF-1-regulated gene DEC1/Stra13: a mechanism for regulation of adipogenesis by hypoxia. Dev Cell 2(3):331-41.